Adamas Pharmaceuticals, Inc.

MD · United States · Reporting entity ID 100000226811

Total reported 2019–2025

$11.5M

#452 of 2,960 reporting companies — 0% of all reported industry payments

$2.36M in general payments across 20,061 records, plus $9.16M in research funding across 3,041 records.

How it breaks down

General payments $2,362,915

Research funding $9,163,263

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.